Bernd R. Binder
#153,258
Most Influential Person Now
Bernd R. Binder's AcademicInfluence.com Rankings
Bernd R. Binderbiology Degrees
Biology
#11610
World Rank
#15015
Historical Rank
Cell Biology
#595
World Rank
#608
Historical Rank
Immunology
#755
World Rank
#777
Historical Rank
Genetics
#1259
World Rank
#1361
Historical Rank
Download Badge
Biology
Why Is Bernd R. Binder Influential?
(Suggest an Edit or Addition)Bernd R. Binder's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Nuclear Factor (NF)-κB–regulated X-chromosome–linked iap Gene Expression Protects Endothelial Cells from Tumor Necrosis Factor α–induced Apoptosis (1998) (711)
- Polar secretion of endothelin-1 by cultured endothelial cells. (1992) (665)
- Cellular origins and thrombogenic activity of microparticles isolated from human atherosclerotic plaques. (2007) (383)
- Identification of patients at low risk for recurrent venous thromboembolism by measuring thrombin generation. (2006) (376)
- Protective role of phospholipid oxidation products in endotoxin-induced tissue damage (2002) (368)
- Novel function for blood platelets and podoplanin in developmental separation of blood and lymphatic circulation. (2010) (292)
- Oxidized Membrane Vesicles and Blebs From Apoptotic Cells Contain Biologically Active Oxidized Phospholipids That Induce Monocyte‐Endothelial Interactions (2002) (286)
- Signaling Molecules of the NF-κB Pathway Shuttle Constitutively between Cytoplasm and Nucleus* (2002) (267)
- Activation of NF-κB by XIAP, the X Chromosome-linked Inhibitor of Apoptosis, in Endothelial Cells Involves TAK1* (2000) (249)
- uPAR – uPA – PAI-1 interactions and signaling: A vascular biologist’s view (2007) (248)
- Serum albumin is a specific inhibitor of apoptosis in human endothelial cells. (1996) (237)
- Plasminogen activator inhibitor 1: physiological and pathophysiological roles. (2002) (225)
- Vascular endothelial cell growth factor-induced tissue factor expression in endothelial cells is mediated by EGR-1. (1999) (223)
- Expression of Heme Oxygenase-1 in Human Vascular Cells Is Regulated by Peroxisome Proliferator-Activated Receptors (2007) (208)
- Oxidized phospholipids stimulate tissue factor expression in human endothelial cells via activation of ERK/EGR-1 and Ca(++)/NFAT. (2002) (205)
- Oxidized Phospholipids Induce Expression of Human Heme Oxygenase-1 Involving Activation of cAMP-responsive Element-binding Protein* (2003) (201)
- Specificity, diversity, and convergence in VEGF and TNF‐α signaling events leading to tissue factor up regulation via EGR‐1 in endothelial cells (2001) (197)
- Antiinflammatory activity of astragaloside IV is mediated by inhibition of NF-κB activation and adhesion molecule expression (2003) (182)
- Urokinase Receptor Is Associated with the Components of the JAK1/STAT1 Signaling Pathway and Leads to Activation of This Pathway upon Receptor Clustering in the Human Kidney Epithelial Tumor Cell Line TCL-598* (1997) (181)
- M6P/IGFII‐receptor complexes urokinase receptor and plasminogen for activation of transforming growth factor‐β1 (1999) (166)
- Oxidized Phospholipids Trigger Atherogenic Inflammation in Murine Arteries (2005) (158)
- Constant Darkness Induces IL-6-Dependent Depression-Like Behavior through the NF-κB Signaling Pathway (2011) (154)
- Simvastatin Reduces the Expression of Adhesion Molecules in Circulating Monocytes From Hypercholesterolemic Patients (2003) (152)
- Hepatocyte growth factor increases expression of vascular endothelial growth factor and plasminogen activator inhibitor-1 in human keratinocytes and the vascular endothelial growth factor receptor flk-1 in human endothelial cells. (1999) (148)
- Circadian Fluctuations of Plasminogen Activator Inhibitor and Tissue Plasminogen Activator Levels in Plasma of Patients with Unstable Coronary Artery Disease and Acute Myocardial Infarction (1988) (143)
- C5a stimulates production of plasminogen activator inhibitor-1 in human mast cells and basophils. (2002) (139)
- Cardiac malformations and myocardial abnormalities in podoplanin knockout mouse embryos: Correlation with abnormal epicardial development (2008) (137)
- Disruption of the protein C inhibitor gene results in impaired spermatogenesis and male infertility. (2000) (136)
- Oxidized Phospholipids Regulate Expression of ATF4 and VEGF in Endothelial Cells via NRF2-Dependent Mechanism: Novel Point of Convergence Between Electrophilic and Unfolded Protein Stress Pathways (2010) (135)
- Isolation of cDNA clones coding for IgE autoantigens with serum IgE from atopic dermatitis patients (1998) (135)
- Vascular endothelial growth factor (VEGF) induces rapid prourokinase (pro-uPA) activation on the surface of endothelial cells. (2004) (134)
- Oxidized Phospholipids Stimulate Angiogenesis Via Autocrine Mechanisms, Implicating a Novel Role for Lipid Oxidation in the Evolution of Atherosclerotic Lesions (2006) (134)
- Signaling molecules of the NF-kappa B pathway shuttle constitutively between cytoplasm and nucleus. (2002) (134)
- Genetic engineering of a hypoallergenic trimer of the major birch pollen allergen, Bet v 1 (2001) (133)
- The somatomedin B domain of vitronectin. Structural requirements for the binding and stabilization of active type 1 plasminogen activator inhibitor. (1994) (132)
- Proliferation of a human epidermal tumor cell line stimulated by urokinase (1987) (130)
- The 4G/5G Sequence Polymorphism in the Promoter of Plasminogen Activator Inhibitor-1 (PAI-1) Gene: Relationship to Plasma PAI-1 Level in Venous Thromboembolism (1998) (129)
- Purification and characterization of human vascular plasminogen activator derived from blood vessel perfusates. (1979) (129)
- Oxidized Phospholipids Negatively Regulate Dendritic Cell Maturation Induced by TLRs and CD401 (2005) (118)
- Impact of adipose tissue on plasma plasminogen activator inhibitor-1 in dieting obese women. (1999) (114)
- Direct binding of Nur77/NAK-1 to the plasminogen activator inhibitor 1 (PAI-1) promoter regulates TNF alpha -induced PAI-1 expression. (2003) (113)
- Endogenous Fibrinolytic System in Chronic Large‐Vessel Thromboembolic Pulmonary Hypertension (1992) (112)
- Coagulation factors II, V, VII, and X, prothrombin gene 20210G-->A transition, and factor V Leiden in coronary artery disease: high factor V clotting activity is an independent risk factor for myocardial infarction. (1999) (109)
- Oxidized Phospholipids Are More Potent Antagonists of Lipopolysaccharide than Inducers of Inflammation (2010) (108)
- Activation of Nuclear Factor-&kgr;B Significantly Contributes to Lumen Loss in a Rabbit Iliac Artery Balloon Angioplasty Model (2002) (106)
- Analysis of inflammatory gene induction by oxidized phospholipids in vivo by quantitative real-time RT-PCR in comparison with effects of LPS. (2002) (104)
- ATF4-dependent transcription is a key mechanism in VEGF up-regulation by oxidized phospholipids: critical role of oxidized sn-2 residues in activation of unfolded protein response. (2008) (102)
- NAB2, a Corepressor of EGR-1, Inhibits Vascular Endothelial Growth Factor-mediated Gene Induction and Angiogenic Responses of Endothelial Cells* (2003) (100)
- The mast cell as site of tissue-type plasminogen activator expression and fibrinolysis. (1999) (95)
- A novel G/A and the 4G/5G polymorphism within the promoter of the plasminogen activator inhibitor-1 gene in patients with deep vein thrombosis. (1996) (95)
- The plasminogen activator inhibitor "paradox" in cancer. (2008) (94)
- Efficient phagocytosis of periodontopathogens by neutrophils requires plasma factors, platelets and TLR2 (2011) (94)
- Myeloid PTEN Promotes Inflammation but Impairs Bactericidal Activities during Murine Pneumococcal Pneumonia (2010) (93)
- Functional inhibition of endogenously produced urokinase decreases cell proliferation in a human melanoma cell line. (1989) (90)
- Granulocyte proteases and hydrogen peroxide synergistically inactivate thrombomodulin of endothelial cells in vitro. (1994) (89)
- Involvement of low-density lipoprotein receptor-related protein (LRP) in the clearance of factor VIII in von Willebrand factor-deficient mice. (2000) (88)
- Multi-Hit Inhibition of Circulating and Cell-Associated Components of the Toll-Like Receptor 4 Pathway by Oxidized Phospholipids (2009) (87)
- Sandwich ELISA for t-PA antigen employing a monoclonal antibody. (1986) (87)
- Dynamics of NF κB and IκBα Studied with Green Fluorescent Protein (GFP) Fusion Proteins (2000) (87)
- Purification and identification of the lipoprotein-binding proteins from human blood platelet membrane. (1989) (86)
- Purification of an active plasminogen activator inhibitor immunologically related to the endothelial type plasminogen activator inhibitor from the conditioned media of a human melanoma cell line. (1986) (82)
- Vascular Endothelial Growth Factor Receptor-2–Induced Initial Endothelial Cell Migration Depends on the Presence of the Urokinase Receptor (2004) (80)
- A Decrease in Plasminogen Activator Inhibitor-1 Activity after Successful Percutaneous Transluminal Coronary Angioplasty Is Associated with a Significantly Reduced Risk for Coronary Restenosis (1992) (79)
- Molecular and Functional Characterization of the Urokinase Receptor on Human Mast Cells* (1997) (79)
- Fibrinogen, t-PA, and PAI-1 plasma levels in patients with pulmonary hypertension. (1994) (79)
- Urokinase-type plasminogen activator as a marker for the formation of distant metastases in prostatic carcinomas. (1988) (78)
- Endogenous receptor-bound urokinase mediates tissue invasion of the human lung carcinoma cell lines A549 and Calu-1. (1992) (76)
- Inhibition of tissue kallikrein by protein C inhibitor. Evidence for identity of protein C inhibitor with the kallikrein binding protein. (1992) (74)
- Thrombin Stimulates Expression of Tissue-Type Plasminogen Activator and Plasminogen Activator lnhibitor Type 1 in Cultured Human Vascular Smooth Muscle Cells (1993) (73)
- The isoprostane 8‐iso‐PGF2α stimulates endothelial cells to bind monocytes: difference to thromboxane‐mediated endothelial activation (2001) (72)
- The human HERC family of ubiquitin ligases: novel members, genomic organization, expression profiling, and evolutionary aspects. (2005) (71)
- Sustained expression of early growth response protein-1 blocks angiogenesis and tumor growth. (2006) (70)
- VEGF-induced endothelial cell migration requires urokinase receptor (uPAR)-dependent integrin redistribution. (2012) (70)
- The role of the plasminogen activation system in cancer. (1999) (69)
- Plasminogen activator activity in bone metastases of prostatic carcinomas as compared to primary tumors. (1985) (69)
- Plasminogen Activator Inhibitor 1 Expression is Regulated by the Inflammatory Mediators Interleukin-1α, Tumor Necrosis Factor-α, Transforming Growth Factor-β and Oncostatin M in Human Cardiac Myocytes ☆ (2002) (68)
- Anti‐inflammatory properties of the PI3K pathway are mediated by IL‐10/DUSP regulation (2010) (65)
- Notoginsenoside R1 counteracts endotoxin-induced activation of endothelial cells in vitro and endotoxin-induced lethality in mice in vivo. (1997) (64)
- Inhibition of acrosin by protein C inhibitor and localization of protein C inhibitor to spermatozoa. (1994) (62)
- Mannose 6-phosphate/insulin-like growth factor 2 receptor limits cell invasion by controlling alphaVbeta3 integrin expression and proteolytic processing of urokinase-type plasminogen activator receptor. (2008) (62)
- Podoplanin deficient mice show a rhoa‐related hypoplasia of the sinus venosus myocardium including the sinoatrial node (2009) (62)
- Specific monocyte adhesion to endothelial cells induced by oxidized phospholipids involves activation of cPLA2 and lipoxygenase Published, JLR Papers in Press, February 5, 2006. (2006) (62)
- Tissue plasminogen activator inhibitor in human plasma: development of a functional assay system and demonstration of a correlating Mr = 50,000 antiactivator. (1985) (62)
- The N Terminus of Mannose 6-Phosphate/Insulin-like Growth Factor 2 Receptor in Regulation of Fibrinolysis and Cell Migration* (2002) (62)
- HERC5, a HECT E3 ubiquitin ligase tightly regulated in LPS activated endothelial cells (2004) (60)
- Complex formation between urokinase and plasma protein C inhibitor in vitro and in vivo. (1989) (60)
- TGF-β-induced apoptosis in endothelial cells mediated by M6P/IGFII-R and mini-plasminogen (2005) (60)
- Isolation and characterization of plasminogen activators from hyperplastic and malignant prostate tissue. (1984) (60)
- Elevated levels of plasma prekallikrein, high molecular weight kininogen and factor XI in coronary heart disease. (2002) (60)
- GMCSF activates NF-κB via direct interaction of the GMCSF receptor with IκB kinase β (2003) (60)
- New Aspects in Thrombosis Research: Possible Role of Mast Cells as Profibrinolytic and Antithrombotic Cells (2002) (59)
- Urokinase mediates endothelial cell survival via induction of the X-linked inhibitor of apoptosis protein. (2009) (59)
- Photooxidation Generates Biologically Active Phospholipids That Induce Heme Oxygenase-1 in Skin Cells* (2007) (57)
- Indirubin-3′-Monoxime Blocks Vascular Smooth Muscle Cell Proliferation by Inhibition of Signal Transducer and Activator of Transcription 3 Signaling and Reduces Neointima Formation In Vivo (2010) (57)
- Clinical value of determination of urokinase-type plasminogen activator antigen in plasma for detection of colorectal cancer: comparison with circulating tumor-associated antigens CA 19-9 and carcinoembryonic antigen. (1993) (56)
- Polymorphic membrane protein (PMP) 20 and PMP 21 of Chlamydia pneumoniae induce proinflammatory mediators in human endothelial cells in vitro by activation of the nuclear factor-kappaB pathway. (2003) (54)
- Plasminogen Activator Inhibitor-1 Levels in Patients with Chronic Angina Pectoris with or without Angiographic Evidence of Coronary Sclerosis (1990) (54)
- Factors Contributing to Increased Vascular Fibrinolytic Activity in Mongrel Dogs (1993) (53)
- Mechanisms of Signaling through Urokinase Receptor and the Cellular Response (1999) (52)
- Inhibition of restenosis by tissue factor pathway inhibitor: in vivo and in vitro evidence for suppressed monocyte chemoattraction and reduced gelatinolytic activity. (2004) (51)
- Analysis of oxidized phospholipids by MALDI mass spectrometry using 6-aza-2-thiothymine together with matrix additives and disposable target surfaces. (2010) (51)
- Hyperthermia stimulates plasminogen activator inhibitor type 1 expression in human umbilical vein endothelial cells in vitro. (1991) (51)
- ATTENUATION OF ENDOTOXIN‐INDUCED PULMONARY VASCULAR INJURY BY ANTITHROMBIN III.: 653 (1997) (49)
- Nuclear factor of activated T cells and early growth response-1 cooperate to mediate tissue factor gene induction by vascular endothelial growth factor in endothelial cells (2007) (48)
- Deciphering Regulatory Patterns of Inflammatory Gene Expression From Interleukin-1–Stimulated Human Endothelial Cells (2004) (48)
- Oxidized Cholesteryl Linoleates Stimulate Endothelial Cells to Bind Monocytes via the Extracellular Signal–Regulated Kinase 1/2 Pathway (2002) (48)
- Hepatic synthesis and clearance of components of the fibrinolytic system in healthy volunteers and in patients with different stages of liver cirrhosis. (1991) (47)
- Evaluation of fibrinolytic capacity by a combined assay system for tissue-type plasminogen activator antigen and function using monoclonal anti-tissue-type plasminogen activator antibodies. (1987) (46)
- Inhibition of microvascular endothelial apoptosis in tissue explants by serum albumin. (1999) (46)
- Concentration of endogenous tPA antigen in coronary artery disease: relation to thrombotic events, aspirin treatment, hyperlipidemia, and multivessel disease. (1998) (46)
- Characterization of a specific anti-human urokinase antibody: development of a sensitive competition radioimmunoassay for urokinase antigen. (1984) (45)
- Characterization of IgE–Reactive Autoantigens in Atopic Dermatitis (1999) (45)
- No association of APC resistance with myocardial infarction. (1995) (45)
- VIGR – a novel inducible adhesion family G‐protein coupled receptor in endothelial cells (2004) (43)
- Plasminogen activator inhibitor 1 expression is regulated by the inflammatory mediators interleukin-1alpha, tumor necrosis factor-alpha, transforming growth factor-beta and oncostatin M in human cardiac myocytes. (2002) (43)
- Hepatocyte growth factor stimulates expression of plasminogen activator inhibitor type 1 and tissue factor in HepG2 cells. (1994) (43)
- What Have Mast Cells To Do with Edema Formation, the Consecutive Repair and Fibrinolysis? (1997) (43)
- Growth stimulation of human epidermal cells by urokinase is restricted to the intact active enzyme. (1989) (43)
- Identification of a Novel Exon in Apolipoprotein E Receptor 2 Leading to Alternatively Spliced mRNAs Found in Cells of the Vascular Wall but Not in Neuronal Tissue* (2001) (42)
- Enhanced fibrinolysis caused by tissue plasminogen activator release in hemodialysis. (1987) (42)
- GMCSF activates NF-kappaB via direct interaction of the GMCSF receptor with IkappaB kinase beta. (2003) (42)
- Histopathological findings in experimental aneurysms embolized with conventional and thrombogenic/antithrombolytic Guglielmi coils. (1999) (41)
- The Interferon Stimulated Gene 12 Inactivates Vasculoprotective Functions of NR4A Nuclear Receptors (2012) (40)
- Pulmonary Vein, Dorsal Atrial Wall and Atrial Septum Abnormalities in Podoplanin Knockout Mice With Disturbed Posterior Heart Field Contribution (2009) (40)
- Dynamics of NF kappa B and Ikappa Balpha studied with green fluorescent protein (GFP) fusion proteins. Investigation of GFP-p65 binding to DNa by fluorescence resonance energy transfer. (2000) (39)
- Genetics, genomics and proteomics in atherosclerosis research (2005) (39)
- Urokinase type plasminogen activator receptor is involved in insulin‐like growth factor‐induced migration of rhabdomyosarcoma cells in vitro (2003) (39)
- Rapid Isolation of High Molecular Weight Urokinase from Native Human Urine (1982) (39)
- Expression of recombinant human factor VIII in milk of several generations of transgenic rabbits (2007) (38)
- The isoprostane 8-iso-PGE2 stimulates endothelial cells to bind monocytes via cyclic AMP- and p38 MAP kinase-dependent signaling pathways. (2003) (38)
- Genotype ‐phenotype correlation in myotonic dystrophy (1998) (38)
- Human fibroblasts downregulate plasminogen activator inhibitor type-1 in cultured human macrovascular and microvascular endothelial cells. (1996) (38)
- Type 1 plasminogen activator inhibitor synthesis of endothelial cells is downregulated by smooth muscle cells. (1993) (37)
- Targeting of VEGF‐dependent transendothelial migration of cancer cells by bevacizumab (2010) (37)
- Direct evidence for systemic fibrinogenolysis in patients with acquired α2‐plasmin inhibitor deficiency (1994) (37)
- Pattern of fibrinolytic parameters in patients with gastrointestinal carcinomas (1987) (37)
- Regulation of protein C inhibitor (PCI) activity by specific oxidized and negatively charged phospholipids. (2007) (36)
- Plasma protein C inhibitor is elevated in survivors of myocardial infarction. (1997) (36)
- Matrix-bound plasminogen activator inhibitor type 1 inhibits the invasion of human monocytes into interstitial tissue. (1990) (35)
- Urinary protein C inhibitor. Glycosaminoclycans synthesized by the epithelial kidney cell line TCL-598 enhance its interaction with urokinase. (1991) (35)
- Anisodamine Counteracts Lipopolysaccharide-Induced Tissue Factor and Plasminogen Activator Inhibitor-1 Expression in Human Endothelial Cells: Contribution of the NF-κB Pathway (2001) (35)
- Signal Integration and Coincidence Detection in the Mitogen-activated Protein Kinase/Extracellular Signal-regulated Kinase (ERK) Cascade (2011) (35)
- Plasminogen activators, plasminogen activator inhibitor, and fibronectin in human granulosa cells and follicular fluid related to oocyte maturation and intrafollicular gonadotropin levels. (1990) (35)
- Soluble M6P/IGF2R Released by TACE Controls Angiogenesis via Blocking Plasminogen Activation (2011) (34)
- Binding of urinary protein C inhibitor to cultured human epithelial kidney tumor cells (TCL-598). The role of glycosaminoglycans present on the luminal cell surface. (1994) (34)
- The urokinase receptor (CD87) represents a central mediator of growth factor-induced endothelial cell migration (2012) (33)
- Circadian Fluctuations in Plasma Levels of Tissue Plasminogen Activator Antigen and Plasminogen Activator Inhibitor Activity (1989) (33)
- Genetic Engineering of Recombinant Hypoallergenic Oligomers of the Major Birch Pollen Allergen, Bet v 1: Candidates for Specific Immunotherapy (1999) (33)
- Characterization of IgE–Reactive Autoantigens in Atopic Dermatitis 1. Subcellular Distribution and Tissue–Specific Expression (1999) (32)
- Effect of urokinase on the proliferation of primary cultures of human prostatic cells. (1987) (32)
- Evaluation of Fibrinolytic Capacity in Plasma during Thrombolytic Therapy with Single (scu-PA) or Two-chain Urokinase Type Plasminogen Activator (tcu-PA) by a Combined Assay System for Urokinase Type Plasminogen Activator Antigen and Function (1989) (32)
- Density enhanced phosphatase-1 down-regulates urokinase receptor surface expression in confluent endothelial cells. (2011) (31)
- Highly homologous HERC proteins localize to endosomes and exhibit specific interactions with hPLIC and Nm23B (2008) (31)
- Thrombin Augments Vascular Cell-dependent Migration of Human Mast Cells: Role of MGF (1997) (31)
- Involvement of CK2 in activation of electrophilic genes in endothelial cells by oxidized phospholipids[S] (2011) (30)
- Synthesis and ultrastructural localization of protein C inhibitor in human platelets and megakaryocytes. (1999) (29)
- Urokinase Antigen in Plasma of Patients with Liver Cirrhosis and Hepatoma (1985) (29)
- Predictive value of plasma plasminogen activator inhibitor‐1 for coronary restenosis: dependence on stent implantation and antithrombotic medication (2005) (29)
- Impairment of the Plasmin Activation System in Primary Pulmonary Hypertension: Evidence for Gender Differences (2001) (29)
- Plasminogen activation in diabetes mellitus. Kinetic analysis of plasmin formation using components isolated from the plasma of diabetic donors. (1984) (28)
- Inhibition of the endothelial cell activation by antithrombin in vitro (2004) (28)
- Hyperfibrinolysis in a case of myelodysplastic syndrome with leukemic spread of mast cells (1999) (28)
- Determination of plasma urokinase-type plasminogen activator antigen in patients with primary liver cancer: characterization as tumor-associated antigen and comparison with alpha-fetoprotein. (1992) (27)
- ISG12 is a critical modulator of innate immune responses in murine models of sepsis☆ (2013) (27)
- Mitogenic effect of urokinase on malignant and unaffected adjacent human renal cells. (1988) (27)
- Function of receptor-bound urokinase. (1991) (27)
- Protein C inhibitor (PCI). (1996) (27)
- Direct evidence for systemic fibrinogenolysis in a patient with metastatic prostatic cancer. (1992) (26)
- Binding of retinoic acid by the inhibitory serpin protein C inhibitor. (2001) (26)
- Molecular cloning and tissue distribution of mouse protein C inhibitor (PCI). (1996) (25)
- Heparin binding of protein-C inhibitor--analysis of the effect of heparin on the interaction of protein-C inhibitor with tissue kallikrein. (1997) (25)
- Increased plasma levels of plasminogen activator inhibitor-1 and soluble vascular cell adhesion molecule after triacylglycerol infusion in man (2003) (25)
- The antibody to plasminogen activator inhibitor-1 suppresses pulmonary metastases of human fibrosarcoma in athymic mice. (1995) (24)
- Kinetic analysis of plasminogen activation by purified plasma kallikrein. (1985) (24)
- High precision measurement of electrical resistance across endothelial cell monolayers (1995) (24)
- Crosstalk between the NF-κB activating IKK-complex and the CSN signalosome (2009) (23)
- Plasminogen Activation in Diabetes mellitus (1988) (23)
- The ACE-inhibitor lisinopril affects plasma insulin levels but not fibrinolytic parameters. (1996) (23)
- Plasminogen activation by tissue plasminogen activator in the presence of stimulating CNBr fragment FCB-2 of fibrinogen is a two-phase reaction. Kinetic analysis of the initial phase of slow plasmin formation. (1988) (23)
- Plasmin Activation System in Restenosis: Role in Pathogenesis and Clinical Prediction? (1999) (22)
- In vitro induction of endothelial cell fibrinolytic alterations by Nigella sativa. (2005) (22)
- Protein C inhibitor is expressed in keratinocytes of human skin. (1999) (22)
- Monoclonal antibodies against plasminogen and alpha-2-antiplasmin: binding to native and modified antigens. (1987) (22)
- Urokinase antigen in plasma: age and sex dependent variations. (1984) (22)
- Monoclonal Antibodies Against Human High Molecular Weight Urinary Urokinase: Application for Affinity Purification of Urinary Prourokinase (1986) (22)
- Physiology and pathophysiology of the fibrinolytic system (1995) (22)
- Heparin induced increase of t-PA antigen plasma levels in patients with unstable angina: no evidence for clinical benefit of heparinization during the initial phase of treatment. (1989) (21)
- Male fertility and protein C inhibitor/plasminogen activator inhibitor-3 (PCI): localization of PCI in mouse testis and failure of single plasminogen activator knockout to restore spermatogenesis in PCI-deficient mice. (2007) (21)
- Role of granulocyte elastase in the formation of hemorrhagic shock-induced gastric mucosal lesions in the rat. (1996) (21)
- Genotype-phenotype correlation in myotonic dystrophy. (1998) (21)
- Hemostatic and fibrinolytic parameters in survivors of myocardial infarction: a low plasma level of plasmin–α2-antiplasmin complex is an independent predictor of coronary re-events (2001) (21)
- Increased urokinase activity to antigen ratio in human renal‐cell carcinoma (1985) (20)
- Tissue plasminogen activator activity in prostatic cancer. (1984) (20)
- Clot Lysis Mediated by Cultured Human Microvascular Endothelial Cells (1988) (20)
- Molecular cloning and sequence analysis of the mouse protein C inhibitor gene. (1997) (20)
- Tissue-type plasminogen activator and Type-1 plasminogen activator inhibitor in patients with coronary artery disease — Relations to clinical variables and cardiovascular risk factors (1995) (19)
- Plasma urokinase-type plasminogen activator correlates to bone scintigraphy in prostatic carcinoma. (1988) (19)
- Thymic medullar conduits-associated podoplanin promotes natural regulatory T cells. (2013) (19)
- Increased Plasma Levels of Urokinase-Type Plasminogen Activator With Endometrial and Cervical Cancer (1988) (19)
- Identification of [hydroxyproline3]‐lysyl‐bradykinin released from human kininogens by human urinary kallikrein (1988) (19)
- A novel application for murine double minute 2 antagonists: the p53 tumor suppressor network also controls angiogenesis. (2007) (18)
- Competition of activated protein C and urokinase for a heparin‐dependent inhibitor 1 (1988) (18)
- Variations of components of the plasminogen activation system with the cell cycle in benign prostate tissue and prostate cancer. (2001) (18)
- In vivo inhibition of low density lipoprotein receptor-related protein improves survival of factor VIII in the absence of von Willebrand factor. (2000) (18)
- Differential Regulation of Vitronectin in Mice and Humans in Vitro(*) (1996) (18)
- Increased proteolytic activity on the surface of monocytes from patients with rheumatoid arthritis. (2010) (17)
- Relationship between plasma levels of components of the fibrinolytic system and acute‐phase reactants in patients with uterine malignancies (1990) (17)
- M 6 P / IGFII-receptor complexes urokinase receptor and plasminogen for activation of transforming growth factor-I 1 (1999) (17)
- Fibrinolytic parameters in spermatozoas and seminal plasma. (1991) (17)
- Gabexate mesilate, a synthetic anticoagulant, inhibits the expression of endothelial leukocyte adhesion molecules in vitro* (2003) (17)
- Plasminogen activator inhibitor-1 accelerates lung metastasis formation of human fibrosarcoma cells. (1997) (17)
- Effect of Antihypertensive Treatment with Doxazosin on Insulin Sensitivity and Fibrinolytic Parameters (1998) (16)
- Integration and expression of the WAP-hPC gene in three generations of transgenic rabbits (2002) (16)
- Plasminogen activators and plasminogen activator inhibitor in malignant and non‐malignant ascitic fluid (1988) (16)
- A comparison between activated protein C and des-1-41-light chain-activated protein C in reactions with type 1 plasminogen activator inhibitor. (1989) (16)
- Nonenzymatic glucosylation as a contributing factor to defective fibrinolysis in diabetes mellitus. (1986) (16)
- Canalicular Fragmentation of Apoptotic Human Endothelial Cells (1996) (16)
- Fibrinolytic proteins in apoptotic human umbilical vein endothelial cells. (1998) (16)
- Predictive Value of PAI-1 Plasma Activity and Thallium Perfusion Imaging for Restenosis after Percutaneous Transluminal Angioplasty in Clinically Asymptomatic Patients (1999) (16)
- Pattern of fibrinolytic parameters in patients with gastrointestinal carcinomas. (1987) (15)
- Isolation and characterization of tissue-type plasminogen activator- binding proteoglycans from human umbilical vein endothelial cells. (1996) (15)
- Changes in the fibrinolytic system in patients with peripheral arterial occlusive disease undergoing percutaneous transluminal angioplasty. (1999) (15)
- Allosteric regulation of tPA-mediated plasminogen activation by a modifier mechanism: evidence for a binding site for plasminogen on the tPA A-chain. (1992) (14)
- The role of type-1 plasminogen activator inhibitor in failure of thrombolytic therapy with recombinant tissue plasminogen activator. (1993) (14)
- CROSSTALK BETWEEN THE NF-KAPPA B ACTIVATING IKK-COMPLEX AND THE CSN SIGNALOSOME (2011) (14)
- Analysis of fibrinolytic proteins in relation to DNA ploidy in prostate cancer (1998) (14)
- Effect of Caffein Ingestion on Plasma Fibrinolytic Potential (1988) (14)
- A transcriptional repressor of the tissue factor gene in endothelial cells. (1999) (13)
- Tissue-type plasminogen activator and urokinase: differences in the reaction pattern with the active-site titrant 4-methylumbelliferyl-p-guanidinobenzoate hydrochloride. (1987) (13)
- Functional characterization of monoclonal antibodies directed against fibrin binding domains of tissue-type plasminogen activator. (1989) (13)
- A functional screening assay for the isolation of transcription factors. (2002) (13)
- Autoantibody Reactivity in a Case of Schnitzler’s Syndrome: Evidence for a Th1-Like Response and Detection of IgG2 Anti-FcεRIα Antibodies (2000) (13)
- Glycosaminoglycans Regulate the Enzyme Specificity of Protein C Inhibitor (1992) (13)
- Stimulation of Tissue Factor Expression in Human Microvascular and Macrovascular Endothelial Cells by Cultured Vascular Smooth Muscle Cells in vitro (1999) (13)
- Plasminogen Activation in Diabetes Mellitus: Normalization of Blood Sugar Levels Improves Impaired Enzyme Kinetics In Vitro (1985) (12)
- Comparison of fibrinolytic activities of human and bovine endothelial cells. (1988) (12)
- Influence of Cardiac Output on Peak t-PA Plasma Levels in Patients Receiving Thrombolytic Therapy with Recombinant Tissue-Type Plasminogen Activator – Correlation with Patency Rate (1993) (11)
- Localization and immunological characterization of plasminogen activators in human prostate tissue. (1983) (11)
- Inhibition of Neointimal Formation after Stent Placement with Adenovirus-mediated Gene Transfer of IκBα in the Hypercholesterolemic Rabbit Model: Initial Results (2002) (10)
- Elevated tissue type plasminogen activator in human granulosa cells correlates with fertilizing capacity. (1988) (10)
- Theileria parva 104 kDa microneme--rhoptry protein is membrane-anchored by a non-cleaved amino-terminal signal sequence for entry into the endoplasmic reticulum. (1999) (10)
- Azelaic acid decreases the fibrinolytic potential of cultured human melanoma cells in vitro. (1996) (10)
- ATF 4-dependent transcription is a key mechanism in VEGF up-regulation by oxidized phospholipids : critical role of oxidized sn2 residues in activation of unfolded protein response * (2008) (10)
- Effect of hypophysectomy on the tissue and blood plasminogen activator activity in the rat. (1985) (9)
- Chromogenic substrate autography: a method for detection, characterization, and quantitative measurement of serine proteases after sodium dodecyl sulfate-polyacrylamide gel electrophoresis or isoelectric focusing in polyacrylamide gels. (1985) (9)
- Influence of urokinase on cell proliferation and invasion. (1990) (9)
- Protease Dependent Activation of Endothelial Cells by Peritoneal Dialysis Effluents (1999) (9)
- Protein C inhibitor (PCI) and heparin cofactor II (HCII): possible alternative roles of these heparin-binding serpins outside the hemostatic system. (1997) (9)
- Plasminogen activation in diabetes mellitus. Kinetics of plasmin formation with tissue plasminogen activator and plasminogen from individual diabetic donors and with in vitro glucosylated plasminogen. (1988) (9)
- Does Plasma Urokinase Antigen Reflect Tumor Urokinase in Prostatic Carcinoma? (1985) (8)
- Some endocrine traits of transgenic rabbits. I. Changes in plasma and milk hormones. (2008) (8)
- Organization of the gene encoding mouse vitronectin. (1993) (8)
- Myotonic dystrophy: molecular genetics and diagnosis. (1998) (7)
- Modulation of heparin cofactor II activity by glycosaminoglycans and adhesive glycoproteins. (1992) (7)
- Fibronectin decreases the stimulatory effect of fibrin and fibrinogen fragment FCB-2 on plasmin formation by tissue plasminogen activator. (1991) (7)
- Assessment of Hemostasis (1997) (6)
- Effect of protein C inhibitor (PCI) on in vitro fertilization (1996) (6)
- 127 Plasminogen activator inhibitor 3 (PAI-3, protein C inhibitor): Purification, characterization and specificity (1988) (6)
- Regulation of plasminogen activation in isolated perfused rat kidney. (1989) (6)
- The effect of alloxan-induced diabetes on tissue plasminogen activator activity and plasmin inhibition in the rat. (1981) (6)
- Effect of the cyanogen-bromide-2 fragment of fibrinogen on plasminogen activation by single-chain urokinase-type plasminogen activator. (1987) (6)
- Serine protease inhibitors (serpins) in human seminal plasma: Concentrations and inhibition of acrosin (1994) (6)
- Purification of a Plasminogen Activator from Venous Occlusion Plasma (1979) (5)
- Possible identity of kallikrein binding protein with protein C inhibitor. (1992) (5)
- Oral presentation 31Podoplanin-induced platelet aggregation mediates separation of blood and lymphatic vessels (2006) (5)
- Fibrinolytic Response to Venous Occlusion Compared to Physical Stress Test in Young Patients with Coronary Artery Disease (1999) (5)
- Vitronectin Modulates Glycosaminoglycan Dependent Reactions of Protein C Inhibitor (1992) (5)
- Demonstration of plasminogen activator activity in the intima and media of the normal human aorta and other large arteries: immunological identification of the plasminogen activator(s). (1989) (5)
- Hepatocyte Growth Factor Stimulates Expression of Plasminogen Activator Inhibitor Type 1 and Tissue Factor in HepG 2 Cells (1994) (5)
- Effect of notoginsenoside R1 on the synthesis of components of the fibrinolytic system in cultured human pulmonary artery endothelial cells and human skin microvascular endothelial cells (1995) (5)
- Smooth Muscle Cell Migration Promoting Activity of Plasma Predicts Restenosis in Patients with Peripheral Arterial Occlusive Disease Undergoing Angioplasty (2000) (5)
- Hemodynamics of the isolated perfused rat kidney in the absence and presence of kallikrein substrate. (1986) (5)
- Inhibition of neointimal formation after stent placement with adenovirus-mediated gene transfer of I kappa B alpha in the hypercholesterolemic rabbit model: initial results. (2002) (4)
- Autoantibody reactivity in a case of Schnitzler's syndrome: evidence for a Th1-like response and detection of IgG2 anti-FcepsilonRIalpha antibodies. (2000) (4)
- Effect of caffeine intake on platelet antigen levels of plasminogen activator inhibitor-1 (PAI-1) (1990) (4)
- mp23, a Theileria parva transmembrane protein with homology to the protein disulfide isomerase family. (2002) (4)
- Plasminogen activator inhibitor-1 plasma levels and coronary restenosis. (1992) (4)
- Fibrinolysis in patients with the 1691 G→A mutation in factor V gene and history of deep vein thrombosis (1997) (4)
- Interactions of uPAR: impact on receptor regulation and signal transduction (1998) (4)
- Association of a significant increase of plasminogen activator inhibitor-1 with the development of coronary restenosis in patients after PTCA (1990) (4)
- Phenotype and Ctg-Repeat Size in Myotonic Dystrophy: A Study of 26 Patients and 55 Relatives (1999) (4)
- Changes in Plasminogen Activator Activity and Plasmin Inhibition in the Pig During Experimental Hypovolaemia (1985) (4)
- [Persistent changes in tissue-type plasminogen activator and plasminogen activator inhibitor fibrinolytic parameters in patients following juvenile ischemic cerebral infarct]. (1988) (4)
- 126 Complex formation between urokinase (uPA) and plasma protein C inhibitor (PCI) in vivo (1988) (4)
- Plasminogen activator activity in the aorta of strains of rats with genetically determined different patterns of lipids in the blood. Induction of increased activity by streptozotocin. (1982) (3)
- Distinct expression pattern of estrogen receptor alpha and beta mRNA in cultured human endothelial and vascular smooth muscle cells (1998) (3)
- Criteria and search for specific assays for active plasminogen activator inhibitor 1 (PAI-1) in plasma (2000) (3)
- This information is current as and CD 40 Dendritic Cell Maturation Induced by TLRs Oxidized Phospholipids Negatively Regulate and (2005) (3)
- Plasminogen activation in diabetes mellitus: kinetics of plasmin formation with plasminogen and tissue plasminogen activator from diabetic donors. (1991) (3)
- 21 Hepatocyte growth factor (HGF) stimulates production of plasminogen activator inhibitor-1 (PAI-1) and vascular endothelial growth factor (VEGF) in human keratinocytes and flk-1 in human endothelial cells in vitro (1997) (3)
- Urokinase Receptor (uPAR)-Dependent Integrin Redistribution Represents a Central Mechanism for Growth Factor Induced Endothelial Cell Migration (2010) (3)
- Comparative cross-over study of the effects of lisinopril and doxazosin on insulin, glucose and lipoprotein metabolism and the endogenous fibrinolytic system (1997) (3)
- Isolation And Characterization Of A Plasminogen Activator (PA) From Human Myocardial Tissue (1981) (3)
- Plasmin—α2-antiplasmin complexes (1992) (2)
- Urokinase (uPA) Induces Endothelial Cell Survival Via the X-Linked Inhibitor of Apoptosis Protein (XIAP). (2007) (2)
- Effect of protein C inhibitor (PCI) on in vitro fertilization. (1996) (2)
- [Tissue plasminogen activator activity in early prostatic cancer and in bone metastases of prostatic cancer]. (1984) (2)
- Thrombin is bad, accepted; but is smoking good to prevent restenosis? (2006) (2)
- CIRCADIAN VARIATION OP PLASMINOGEN ACTIVATOR INHIBITOR (PAI) AND THE INCIDENCE OP SEVERE ISCHEMIC ATTACKS IN PATIENTS WITH CORONARY ARTERY DISEASE (CAD) (1987) (2)
- Genetic determinants: is there an "atherosclerosis gene"? (2004) (2)
- Fibrinolytic markers of clinical evolution in tumour patients (1993) (2)
- ID: 348 The density enhanced phosphatase 1 (DEP-1) down-modulates urokinase receptor (uPAR) surface expression in confluent endothelial cells (2006) (2)
- The Effect of Alloxan-Induced Diabetes on Tissue Plasminogen Activator Activity of the Rat (1979) (2)
- Plasmin-α2-antiplasmin complexes (plasmin—plasmin inhibitor complexes) (1999) (2)
- Predictive role of carcinoembryonic antigen (CEA) for therapeutic efficacy of angiogenesis-targeting therapy in colorectal cancer: Novel clinical observation based upon recently discovered CEA biology. (2010) (2)
- , Interleukin-1 — Stimulated Human Endothelial Cells Deciphering Regulatory Patterns of Inflammatory Gene Expression (2004) (2)
- Signal transduction via the urokinase receptor is dependent on both ligand binding and clustering of the receptor in human tumour cell lines (1994) (2)
- Plasminogen activator inhibitors: Biological effects (1990) (2)
- Plasminogen activator inhibitor-1 and transient myocardial ischemia (1989) (2)
- ID: 284 Phosphatidylserine and oxidized phosphatidylethanolamine interact with Protein C Inhibitor (PCI) and modify its activity (2006) (2)
- Urokinase-type plasminogen activator system predicts risk of cardiovascular events in patients with angina pectoris: results of the ECAPTURE study* (2001) (2)
- [Use of monoclonal antibodies in the diagnosis of fibrinolysis]. (1985) (2)
- Localization of the human I-kappaB kinase-beta (IKBKB) to chromosome 8p11.2 by fluorescence in situ hybridization and radiation hybrid mapping. (1998) (1)
- Urinary kallikrein excretion during inhibition of endogenous angiotensin II in the pig (1986) (1)
- Investigation of GFP-p65 binding to DNA by fluorescence resonance energy transfer (FRET) (2000) (1)
- Secretory response of the vessel wall to DDAVP and venous occlusion in von Willebrand's disease. (1994) (1)
- Comparison Between Vascular Plasminogen Activator Activity and Changes in Blood Flow in the Renal Cortex in Pigs (1984) (1)
- Red Blood Cell Derived Microparticles Are Thrombogenic in Mouse Models of Atherosclerosis. (2007) (1)
- 99 Reevaluation of kinetics of plasminogen (Pg) activation by rtPA with and without fibrin fragments over a large substrate concentration ([S]) range (1988) (1)
- Fibrinolysis Plasminogen Activator Expression and The Mast Cell as Site of Tissue-Type (1998) (1)
- Withdrawal: Signal integration and coincidence detection in the mitogen-activated protein kinase/extracellular signal-regulated kinase (ERK) cascade: Concomitant activation of receptor tyrosine kinases and of LRP-1 leads to sustained ERK phosphorylation via down-regulation of dual specificity phosph (2019) (1)
- ISG12 regulates activity of nuclear receptors thereby modulating the vascular response to injury (2007) (1)
- Urokinase-type plasminogen activator system predicts risk of cardiovascular events in patients with angina pectoris: results of the ECAPTURE study. European Concerted Action on Prevention from Thrombosis by URokinase Enhancement. (2001) (1)
- W01.114 Heme oxygenase-1 gene expression is regulated via the peroxisome proliferator-activated receptor (PPAR) alpha (2004) (1)
- Effect of anti plasminogen monoclonal antibodies on whole blood clot lysis. (1988) (1)
- Regulation of vascular remodeling and cardiovascular protection: NFκB and vascular remodeling (2004) (1)
- Characterization of protein c inhibitor (PCI)-binding glycosaminoglycans (GAGs) of epithelial kidney tumor cells (TCL-598) (1994) (1)
- [Pathophysiology of immobilization]. (1999) (1)
- Effect of notoginsenoside R1 on the synthesis of components of the fibrinolytic system in cultured human pulmonary artery vascular cells (1994) (1)
- Overexpression of plasminogen activator inhibitor type-1 in HT-1080 fibrosarcoma cells promotes lung colonization and in vitro cell adhesion (2000) (1)
- Localization of the Human I-κB kinase-β (IKBKB) to Chromosome 8p11.2 by Fluorescencein SituHybridization and Radiation Hybrid Mapping ☆ (1998) (1)
- RELATION OP FIBRIN STIMULATION OF tPA MEDIATED PLASMINOGEN ACTIVATION AND FIBRIN BINDING TOWARDS FIBRONEKTIN AS REVEALED BY A MONOCLONAL ANTIBODY (MAB) AGAINST FCB-2 FIBRINOGEN FRAGMENTS (1987) (0)
- THROMBOGENICITY OF MICROPARTICLES DERIVED FROM VASCULAR CELLS (2007) (0)
- Microparticles Are a Major Determinant of Thrombin Generation Measured by Technothrombin®TGA. (2006) (0)
- Functional characterization of a monoclonal anti tissue type plasminogen activator (t-PA) antibody stimulating plasminogen activator activity of t-PA (1986) (0)
- The effect of the anabolic steroid stanozolol on tissue plasminogen activator activity and plasmin inhibition in the rat (1980) (0)
- Urokinase-type plasminogen activator (u-PA) and the risk of coronary events in patients with angina pectoris (AP) (1998) (0)
- The interferon inducible gene 12 (ISG12), a novel factor modulating the vascular response to injury (2006) (0)
- 29 Fibrinolytic parameters and patency rate after thrombolysis with recombinant tissue plasminogen activator (rtPA) in patients with acute myocardial infarction (AMI) (1988) (0)
- This information is current as Murine Pneumococcal Pneumonia Impairs Bactericidal Activities during Myeloid PTEN Promotes Inflammation but (2010) (0)
- Apoptotic Microparticles Derived from Endothelial Cells, Smooth Muscle Cells and Monocytes Induce Thrombin Generation Via Different Pathways. (2005) (0)
- Urokinase: A Specific Markar of Metastasation in Prostatic Carcinoma (1987) (0)
- Protection from Apoptosis of Endothelial Cells by Albumin (1996) (0)
- Progress in Research on Vascular Systems (1999) (0)
- Forum: Brief Communication Variations of Components of the Plasminogen Activation System With the Cell Cycle in Benign Prostate Tissue and Prostate Cancer (2001) (0)
- Abstract 2380: Carcinoembryonic antigen (CEA) directly activates endothelial cells, thereby inducing (tumor)-angiogenesis (2010) (0)
- Cellular origin and thrombogenic activity of microparticles isolated from human atherosclerotic plaques (2006) (0)
- Effect of binding of urokinase to its receptors in a human epidermal tumor cell line, CCL 20.2 (1987) (0)
- Effect of Notoginsenoside Rl on the Synthesis of Tissue-Type Plasminogen Activator and Plasminogen Activator Inhibitor-1 in Cultured Human Umbilical Vein Endothelial Cells (2005) (0)
- High PAI-1 Levels as Marker of Rethrombosis after Successful Coronary Balloon Angioplasty (2019) (0)
- From Molecular Science to the Treatment of Allergy (1999) (0)
- Proliferator-Activated Receptors Expression of Heme Oxygenase-1 in Human Vascular Cells Is Regulated by Peroxisome (2007) (0)
- Flow beats inflammation, but not always (2007) (0)
- M.515 Oxidized phospholipids trigger atherogenic chemokine expression and subsequent monocyte arrest in murine arteries (2004) (0)
- Inducers of Inflammation Antagonists of Lipopolysaccharide than Oxidized Phospholipids Are More Potent (2010) (0)
- Vascular Endothelial Growth Factor (VEGF) Induces Cell Survival Via an Additional Urokinase (uPA)-Dependent Mechanism. (2004) (0)
- Subject Index, Vol. 16, 1986 (1986) (0)
- 28 Conditioned medium from human trophoblast cells stimulates the expression of tissue type plasminogen activator and urokinase-type plasminogen activator receptor by human umbilical vein endothelial cells (1997) (0)
- Effect of anticoagulation and inhibition of PAI-1 activity on initial pulmonary arrest and lung metastasis formation in a nude mouse model with selected clones of human fibrosarcoma HT-1080 cells (1994) (0)
- RED BLOOD CELL DERIVED MICROPARTICLES ARE THROMBOGENIC IN VITRO AND IN MOUSE MODELS OF ATHEROSCLEROSIS IN VIVO (2008) (0)
- residues in activation of unfolded protein response up-regulation by oxidized phospholipids: critical role of oxidized sn-2 ATF4-dependent transcription is a key mechanism in VEGF (2013) (0)
- Signaling in endothelial cells: 10 years Department of Vascular Biology and Thrombosis Research at the Medical University Vienna (2007) (0)
- VEGF and AMD3100-Induced Rapid Mobilization of C-Kit/Sca-1 Positive Murine Bone Marrow Cells and of Gr-1+/CD-11b+ Myeloid Cells Is Impaired in Urokinase (uPA) and Urokinase Receptor (uPAR) Deficient Mice. (2008) (0)
- A pharmaceutical preparation containing a receptor antagonists for the treatment of blood coagulation disorders (1999) (0)
- Alternative targeting of a serpin-type inhibitor by glycosaminoglycans (GAGs): Heparin binding of protein C inhibitor (pci) prevents its interaction with tissue kallikrein (tk) (1994) (0)
- W01.37 Oxidized phospholipids induce accumulation of mononuclear cells in vivo (2004) (0)
- Phosphoinositides and Other Glycerophospholipids Interact with Protein C Inhibitor (PCI) and Modify Its Activity towards Activated Protein C (APC). (2009) (0)
- uPAR -u PA -P AI-1 interactions an ds ignaling: Av ascular biologist' sv ie w (2007) (0)
- Fibronectin (FN) decreases the stimulatory effect of fibrin and fibrinogen fragment FCB-2 on plasmin formation by tissue plasminogen activator (t-PA) (1990) (0)
- PP97 The human carcinoembryonic antigen (CEA) predicts therapeutic response towards VEGF-targeting therapies in colorectal cancer (2009) (0)
- 1WS02-4 NF-κB and vascular remodeling (2003) (0)
- Sunday, 18 July 2010 (2010) (0)
- Phosphatidylserine and Oxidized Phosphatidylethanolamine Interact with Protein C Inhibitor (PCI) and Modify Its Activity. (2005) (0)
- List of Authors and Speakers (1988) (0)
- Abstract 975: Regulation of the Activity of Nuclear Receptors by the Interferon Inducible Gene 12 Modulates the Vascular Response Injury (2006) (0)
- Role of Microparticles in Thrombin Generation in Patients at Risk for Atherothrombosis. (2007) (0)
- W01.6 Oxidized phospholipids stimulate angiogenesis and induce VEGF gene expression (2004) (0)
- and In Vivo (2017) (0)
- in Endothelial Cells Is Mediated by EGR-1 Induced Tissue Factor Expression - Vascular Endothelial Cell Growth Factor (2013) (0)
- Subject Index Vol. 122, 2000 (2000) (0)
- [The vascular wall and fibrinolysis--physiologic aspects]. (1986) (0)
- mast cells and basophils C5a stimulates production of plasminogen activator inhibitor-1 in human (2013) (0)
- Tu-W19:7 Angiogenic effects of oxidized phospholipids are mediated via autocrine stimulation by VEGF, IL-8 and COX-2-derived prostaglandins (2006) (0)
- Reverse fibrin slide technique: A method for localization of plasminogen activator inhibitor activity in tissue sections (1986) (0)
- Urokinase in Different Areas of Renal Cell Carcinomas (1987) (0)
- 45 Formation of capillary tube-like structures in huvecs is regulated in vitro by urokinase-type plasminogen activator via phosphatidylinositol -3 kinase independent signaling pathway (1997) (0)
- Subject Index, Vol. 13, 1983 (1983) (0)
- Smooth muscle cell proliferation due to growth stimulating activity in plasma and serum of patients suffering from arteriosclerosis (1995) (0)
- GMCSF activates NF- (cid:1) B via direct interaction of the GMCSF receptor with I (cid:1) B kinase (cid:2) (2003) (0)
- Contents, Vol. 16, 1986 (1986) (0)
- Increased Urokinase-Type Plasminogen Activator in Tumors of the Urogenital Tract (1985) (0)
- RAPID UROKINASE RECEPTOR (UPAR) AND INTEGRIN REDISTRIBUTION DURING VASCULAR ENDOTHELIAL GROWTH FACTOR (VEGF)-INDUCED ENDOTHELIAL CELL MIGRATION: REGULATION BY PRO-UROKINASE (PRO-UPA) ACTIVATION AND UPAR INTERNALIZATION (2004) (0)
- Influence of Hyperthermia on the Fibrinolytic Potential of Human Endothelial Cells (1991) (0)
- INHIBITION OF SMOOTH MUSCLE CELL MIGRATION BY EPTIFIBATIDE IN VITRO. EPTIFIBATIDE INHIBITS LOCALIZATION OF INTEGRIN αν-SUBUNIT TO FOCAL ADHESIONS (2004) (0)
- X-Linked Inhibitor of Apoptosis Protein (XIAP) Supports Urokinase (uPA)-Induced Endothelial Cell Survival (2008) (0)
- endothelial cells via activation of ERK/EGR-1 and Ca++/NFAT Oxidized phospholipids stimulate tissue factor expression in human (2013) (0)
- Abstract Poster presentations P-10: Signal tranduction and regulation of gene expressionNotoginsenoside R1 counteracts the induction of plasminogen activator inhibitor-1 and tissue factor in response to endotoxin stimulation in vitro and in vivo (1994) (0)
- Vascular endothelial growth factor (VEGF)- induced pro- urokinase (pro-uPA) activation provides an additional mechanism for cell survival by upregulating inhibitor of apoptosis proteins (IAPS) (2006) (0)
- THROMBIN INDUCED MAST CELL CHEMOTAXIS MIGHT PLAY AN ESSENTIAL ROLE IN THROMBOSIS (1999) (0)
- Dynamics of NF k B and I k B a Studied with Green Fluorescent Protein (GFP) Fusion Proteins INVESTIGATION OF GFP-p65 BINDING TO DNA BY FLUORESCENCE RESONANCE ENERGY TRANSFER* (2000) (0)
- PODOPLANIN GENE DEFICIENCY CAUSES LYMPHATIC MALFORMATION AND LYMPHOCYTE DEVELOPMENTAL DEFECTS (2004) (0)
- Effect of endothelin on the regulation of the fibrinolytic system of cultured human vascular smooth muscle cells (1997) (0)
- Plasma levels of u-PA and SCU-PA in patients suffering from coronary heart disease (1994) (0)
- PLASMINOGEN ACTIVATOR ACTIVITY (PAA) IN THE ISOLATED PERFUSED RAT KIDNEY (IPRK) (1987) (0)
- 306 Plasminogen activator inhibitor (PAI-1) levels in plasma of patients with chronic angina pectoris with or without coronary artery sclerosis (1988) (0)
- Quantification of ADAMTS-13 Activity and Antigen from the Same Sample by a Newly Developed Combi-Actibind Assay (TECHNOZYM® ADAMTS-13). (2006) (0)
- Local I-kappa-bα (Iκbα) Gene Therapy for the Reduction of Neointimal Hyperplasia After PTA or Stent Implantation in a Hypercholesterol Rabbit Model (2000) (0)
- Apoptotic microparticles derived from endothelial cells, smooth muscle cells and monocytes induce thrombin generation via different coagulation pathways (2006) (0)
- A pharmaceutical composition comprising a receptor antagonist for the treatment of blood coagulation disorders (1999) (0)
- ID: 311 High PAI-1 and the malignant phenotype: exogenous PAI-1 signals to tumors cells via uPA/uPAR/LDLR-family system and ERK1/2 pathway inducing increased adhesion and integrin redistribution (2006) (0)
- Interaction between insulin, lipids and reduced fibrinolytic activity in rabbit aortic vascular cells (1994) (0)
- ID: 338 Urokinase (uPA) induces cell survival by up-regulating inhibitor of apoptosis proteins (IAPs) (2006) (0)
- Vascular Endothelial Growth Factor (VEGF)-Induced Endothelial Cell Migration Requires Urokinase Receptor (uPAR) for Integrin Redistribution. (2004) (0)
- Evaluation of a Method for Removal and Determination of Thrombogenic Microparticles. (2007) (0)
- Oxidized Phospholipids That Induce Monocyte-Endothelial Interactions Oxidized Membrane Vesicles and Blebs From Apoptotic Cells Contain Biologically Active (2001) (0)
- Cytokine regulation of the murine vitronectin gene: Identification of regulatory sequences for interleukin 6 (1994) (0)
- Th-W60:8 The interferon inducible gene 12, a novel factor modulating the vascular response to injury (2006) (0)
- A Decrease in Plasminogen Activator Inhibitor-1 Activity after Successful PTCA is Associated with a Significantly Reduced Risk for Development of Coronary Restenosis (1991) (0)
- First Experiences with the Measurement of Thrombin Generation (TGA) on the Ceveron® Alpha in the Routine Lab (2008) (0)
- Complex Formation Between Urokinase and Plasma Protein C Inhibitor In Vitro (2005) (0)
- Measurement of Thrombin-Alpha-2-Macroglobulin Complexes Generated in Plasma (2008) (0)
- Technozym ® ADAMTS-13 ANTIGEN ELISA - A New Assay for Specific Quantification of the vWF Cleaving Protease ADAMTS-13. (2005) (0)
- Measurement of Thrombin-Alpha-2-Macroglobulin Complexes Generated in Plasma. (2008) (0)
- UROKINASE (UPA) INDUCES CAPILLARY-LIKE TUBE FORMATION VIA NF-KAPPAB DEPENDENT CELL SURVIVAL AND CDC42 INDUCED CYTOSKELETAL REARRANGEMENT (2004) (0)
- Binding of protein C inhibitor (PCI) to transformed human epithelial kidney (TCL-598): possible role of cellular proteoglycans (1990) (0)
- 180 Effect of rtPA on the contractile response of isolated papillary muscles (1988) (0)
- is downregulated by smooth muscle cells Type 1 plasminogen activator inhibitor synthesis of endothelial cells (2011) (0)
- Thrombogenicity of Microparticles Derived from Vascular Cells. (2006) (0)
- ID: 314 Initial Angiogenic Cell Migration Depends on CD87-D3 Mediated Integrin Internalization (2006) (0)
- PO9-220 UPREGULATION OF VEGF IN ENDOTHELIAL CELLS TREATED WITH OXIDIZED PHOSPHOLIPIDS IS MEDIATED BY UNFOLDED PROTEIN RESPONSE (2007) (0)
- 87 Genetic manipulation of plasminogen activator inhibitor-1 in two distinct cell lines of human fibrosarcoma: Towards understanding the PAI-1 paradox in cancer (1997) (0)
- 4 Inhibition of the urokinase receptror by antisense oligonucleotides reduces proliferation and binding of nuclear extracts to M67SIE sequence of the c-fos promoter in the human kidney epithelial cell line TCL-598 (1997) (0)
- Contents Vol. 122, 2000 (2000) (0)
- ISG12 Is a Critical Modulator of Innate Immune Responses in Animal Models of Septis. (2006) (0)
- Induction of VEGF by Oxidized Phospholipids Is Mediated by Unfolded Protein Response and Nuclear Orphan Receptor-1 (2006) (0)
- Title Page / Table of Contents, Vol. 18, Supplement 1, 1988 (1988) (0)
- The use of endothelial cell plasma membrane vesicles for the study of fibrinolytic enzyme kinetics at the endothelial cell surface (1994) (0)
- 191 Targeted disruption of mouse protein C inhibitor gene (1997) (0)
- Disruption of the protein C inhibitor (PCI) gene does not result in hemostatic abnormalities but in impaired spermatogenesis and infertility in male PCI-/- mice (2000) (0)
- Factors Influencing Thrombin Induced Platelet Release Reaction (1979) (0)
- Effect Of Neuraminidase On Plasmin Formation By Urokinase And The Vascular Plasminogen Activator (1981) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Bernd R. Binder?
Bernd R. Binder is affiliated with the following schools:
